Alnylam Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
CEOYvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees2,230
Employees2,230
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2002
Founded2002
Employees2,230
Employees2,230
ALNY Key Statistics
Market cap52.50B
Market cap52.50B
Price-Earnings ratio1.66K
Price-Earnings ratio1.66K
Dividend yield—
Dividend yield—
Average volume2.05M
Average volume2.05M
High today$398.37
High today$398.37
Low today$393.64
Low today$393.64
Open price$397.00
Open price$397.00
Volume484.64K
Volume484.64K
52 Week high$495.55
52 Week high$495.55
52 Week low$205.87
52 Week low$205.87
Stock Snapshot
The current Alnylam Pharmaceuticals(ALNY) stock price is $397.25, with a market capitalization of 52.5B. The stock trades at a price-to-earnings (P/E) ratio of 1658.99.
During the trading session on 2025-12-31, Alnylam Pharmaceuticals(ALNY) shares reached a daily high of $398.37 and a low of $393.64. At a current price of $397.25, the stock is +0.9% higher than the low and still -0.3% under the high.
Trading volume for Alnylam Pharmaceuticals(ALNY) stock has reached 484.64K, versus its average volume of 2.05M.
Over the past 52 weeks, Alnylam Pharmaceuticals(ALNY) stock has traded between a high of $495.55 and a low of $205.87.
Over the past 52 weeks, Alnylam Pharmaceuticals(ALNY) stock has traded between a high of $495.55 and a low of $205.87.
Analyst ratings
68%
of 31 ratingsBuy
67.7%
Hold
29%
Sell
3.2%
People also own
Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.